Toward identification of common DNA repair process in mutational signatures

Damian Wójtowicz1, Marcin Wierzbiński1, Jan Hoinka2

  • 1University of Warsaw, Faculty of Mathematics, Informatics, and Mechanics, ul. Banacha 202-097, Warszawa, Poland.

Insights

RePrint models DNA repair pathways to reveal shared mechanisms between mutational signatures. This approach aids in predicting DNA repair pathways for cancer therapy, even for unknown mutagenic processes.

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Mutational signatures reveal patterns of DNA mutations from mutagenic processes.
  • Understanding DNA repair pathways is crucial for cancer therapy, but tools for inferring these pathways from signatures are limited.
  • Mutational signatures result from DNA damage and subsequent DNA repair.

Purpose of the Study:

  • To develop a novel computational method, RePrint, for modeling the DNA repair step in mutational signature generation.
  • To infer shared DNA repair mechanisms between mutational signatures using a transformation-based approach.
  • To enable guilt-by-association prediction of DNA repair pathways and inform cancer treatment strategies.

Main Methods:

  • Modeled the DNA repair process as a transformation (RePrint) from damaged nucleotides to repair-related mutation patterns.
  • Quantified similarity between mutational signatures based on their inferred DNA repair transformations.
  • Clustered signatures using RePrint similarity and compared performance against traditional signature-based clustering.

Main Results:

  • RePrint similarity effectively indicates shared DNA repair mechanisms.
  • RePrint-based clustering significantly outperformed signature-based clustering across multiple evaluation metrics.
  • Validated guilt-by-association predictions with existing literature, identifying shared repair mechanisms even with divergent mutational profiles.

Conclusions:

  • RePrint is the first systematic approach to transfer DNA repair information between mutational signatures.
  • This method facilitates the understanding of signatures with unknown origins and aids in developing targeted therapeutic strategies.
  • The open-source implementation of RePrint enables broader application in cancer research and treatment design.